Deficiency of SCAMP5 Triggers Pancreatic β‐Cell Secretory Dysfunction and Apoptosis

Authors:

Abstract
The late stage of type 2 diabetes is characterized by secretory dysfunction and increased β‐cell apoptosis, but the underlying mechanisms are not fully understood. The expression and function of secretory carrier membrane protein 5 (SCAMP5) in β‐cells are unclear. The aim is to explore the role of SCAMP5 in diabetic β‐cell failure. SCAMP5 expression is reduced in β‐cells under diabetic conditions. Notably, SCAMP5 deficiency diminishes insulin secretion, which is involved in reduced Ca V 1.2 expression. Additionally, decreased SCAMP5 triggers β‐cell apoptosis, suggesting the anti‐apoptotic role of SCAMP5 in β‐cells. Mechanistically, SCAMP5 downregulates the protein expression of voltage‐dependent anion channel (VDAC1) and interacts with it, thereby repressing VDAC1‐recruited Bax to mitochondria, thus inhibiting the release of cytochrome c from mitochondria to the cytoplasm, culminating in preventing β‐cell apoptosis. Furthermore, hyperglycemia‐activated carbohydrate‐responsive element‐binding protein (ChREBP) epigenetically represses SCAMP5 expression by reducing trimethylation of histone H3 at lysine 4 (H3K4me3) within the Scamp5 promoter. These findings highlight the essential role of the ChREBP‐controlled SCAMP5 in β‐cell insulin secretion and apoptosis, revealing a previously unrecognized mechanism underlying the β‐cell failure in diabetes.
Funding Information
  • National Natural Science Foundation of China (82070806)
  • National Natural Science Foundation of China (82070845)
  • National Natural Science Foundation of China (82370833)
  • Natural Science Foundation of Guangdong Province (2023A1515010442)
  • Natural Science Foundation of Guangdong Province (2023A1515012688)

This publication has 24 references indexed in Scilit: